CFRXQ — CONTRAFECT Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-Upstart, ContraFect, Evolving Systems
ContraFect: Slumps on discounted share offering
Brief: Contrafect Corporation Prices Public Offering Of Common Stock
Brief: ContraFect Announces Proposed Public Offering Of Common Stock
ContraFect: Jumps on BARDA funding for antibacterial development
Brief: ContraFect Announces BARDA Contract Award For Up To $86.8 Million And Provides Business Outlook
Brief: ContraFect Announces Appointment Of Jane F. Barlow To Board Of Directors
Brief: Contrafect posts Q3 Earnings Per Share $0.12
Brief: Contrafect Expands Access To Exebacase For Treatment Of MRSA Bloodstream Infections In Covid-19 Patients
Brief: Contrafect Announces Funding Agreement With The Cystic Fibrosis Foundation
Brief: ContraFect Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: ContraFect Reports Q2 Loss Per Share $0.88
Brief: Contrafect Announces Up To $18.9 Million In Funding From Carb-X
Brief: ContraFect Appoints Lishan Aklog To Board Of Directors
Brief: Cvi Investments Inc Reports 8.3% Passive Stake In Contrafect Corp As Of May 22
Brief: ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer
Brief: Contrafect Prices Approximately $52.5 Million Public Offering Of Common Stock And Warrants
Brief: ContraFect Announces Proposed Public Offering Of Common Stock And Warrants
Brief: Contrafect Reports Q1 Loss Per Share Of $0.49